How This Dutch AI Startup Is Quietly Changing Hearing Care

Jan de Vries · 2026-08-28

Okay, let's talk about something that doesn't get enough airtime in the startup world—actual, meaningful healthcare innovation. Not another food delivery app, but something that could tangibly improve millions of lives. Clementine, a startup based in Maastricht, the Netherlands, just secured $2 million in Seed funding. That's a significant vote of confidence. Their mission? To tackle one of healthcare's quietest, yet most pervasive, problems: hearing loss. ### The Problem They're Solving Think about it for a second. Hearing loss affects roughly 1.5 billion people globally. That's a staggering number. But here's the kicker: nearly 80% of those people never seek treatment. And for those who finally do? They've typically waited over eight years. Eight years. Why the delay? It's a mix of stigma, fear, and just plain old administrative hassle. People are hesitant. They're worried about judgment. They call a clinic, get put on hold, and the moment passes. The problem gets shelved, year after year. ### Meet Matthew: The AI Agent Bridging the Gap This is where Clementine's core innovation comes in. They've built an AI platform specifically for hearing clinics, and at its heart is "Matthew," an AI hearing care agent. Matthew isn't just a chatbot. It's designed to engage prospective patients directly. The idea is simple, yet powerful: provide a judgment-free, always-available starting point. - It answers questions 24/7—no waiting list, no awkward pauses. - It educates users, gently overcoming both emotional and practical barriers. - It guides people toward the appropriate care, acting as a compassionate first touchpoint. For clinics drowning in calls and administrative work, Matthew can translate inquiries into actual bookings. For patients, it's a low-pressure way to start the conversation they've been avoiding. As founder and CEO Vince van de Weijer puts it: "Clinics don't need more leads; they need better conversations at the right moment. Matthew ensures no patient inquiry goes unanswered." ### The Backing and The Vision The $2 million Seed round was led by Healthy.Capital, an Amsterdam-based early-stage HealthTech investor known for backing smart, scalable solutions. Their managing partner, Douwe Jippes, highlighted the potential, saying Clementine's approach "will fundamentally change how people with hearing disability engage with hearing healthcare." It's not just about the tech. It's about pairing that AI with behavioral science to meet people where they are—long before they're ready to walk into a physical clinic. ### What's Next for Clementine? The timing of this funding is interesting. It comes right after Clementine expanded its commercial reach through a partnership with Zoolstra, a marketing agency that works with hearing clinics across the United States and Canada. That's a clear signal of their ambition to scale beyond Europe. The fresh capital will be used to deepen the AI's capabilities and forge more partnerships—not just with hearing clinics, but with optical retailers and other healthcare organizations. They're building a network. So, while the headline is about a funding round, the real story is about a shift. It's about using thoughtful technology to bridge a critical gap in a massive, underserved market. In a world full of noise, that's a signal worth listening to.